Eledon Pharmaceuticals (ELDN) EPS (Basic) (2013 - 2026)
Eledon Pharmaceuticals' (ELDN) quarterly EPS (Basic) came in at -$0.19 in Q1 2026, down 143.32% YoY from $0.44 in Q1 2025, and up 26.48% on a QoQ basis from -$0.26 in Q3 2025.
Powered by 
Analysis
Eledon Pharmaceuticals (ELDN) EPS (Basic) (2013 - 2026) Analysis & Trends
Eledon Pharmaceuticals (ELDN) has 14 years of EPS (Basic) data on file, last reported at -$0.19 in Q1 2026.
- Quarterly EPS (Basic) fell 143.32% year-over-year to -$0.19 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.59 (up 3.26% YoY) and the FY2025 annual result came in at -$0.52, up 21.52% from the prior year.
- EPS (Basic) grew to -$0.19 in Q1 2026, from -$0.26 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.13 in Q3 2024 to a low of -$4.09 in Q4 2022.
- A 5-year average of -$0.66 and a median of -$0.44 in 2023 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2022 — EPS (Basic) tumbled 587.8% — and 2024, when it surged 132.92%.
- Tracing ELDN's EPS (Basic) over 5 years: stood at -$4.09 in 2022, then soared by 89.63% to -$0.42 in 2023, then tumbled by 59.6% to -$0.68 in 2024, then surged by 61.95% to -$0.26 in 2025, then grew by 26.48% to -$0.19 in 2026.
- The last three EPS (Basic) figures came in at -$0.19 (Q1 2026), -$0.26 (Q3 2025), and -$0.33 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -3.06 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.18 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.06 |
| 10 | Eledon Pharmaceuticals | 344.87 Mn | 344.87 Mn | - | -0.28 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.28 |
| Mar 31, 2026 | -0.19 |
| Sep 30, 2025 | -0.25 |
| Jun 30, 2025 | -0.15 |
| Mar 31, 2025 | -0.08 |
| Dec 31, 2024 | -0.67 |
| Sep 30, 2024 | 0.10 |
| Jun 30, 2024 | -0.27 |
| Mar 31, 2024 | -0.52 |
| Dec 31, 2023 | -0.33 |
| Sep 30, 2023 | -0.30 |
| Jun 30, 2023 | -0.35 |
| Mar 31, 2023 | -0.62 |
| Dec 31, 2022 | -3.28 |
| Sep 30, 2022 | -0.59 |
| Jun 30, 2022 | -0.52 |
| Mar 31, 2022 | -0.55 |
| Dec 31, 2021 | -0.20 |
| Sep 30, 2021 | -0.53 |
| Jun 30, 2021 | -0.40 |